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ABSTRACT
Nerve and blood vessel ingrowth during intervertebral disc degeneration, 
is thought to be a major cause of low back pain, however the regulation of this 
process is poorly understood. Here, we investigated the expression and regulation 
of a subclass of axonal guidance molecules known as the class 3 semaphorins, and 
their receptors; plexins and neuropilins within human NP tissue and their regulation 
by pro-inlammatory cytokines. Importantly this determined whether semaphorin 
expression was associated with the presence of nerves and blood vessels in tissues 
from human intervertebral discs. The study demonstrated that semaphorin3A, 3C, 
3D, 3E and 3F and their receptors were expressed by native NP cells and further 
demonstrated their expression was regulated by IL-1β but to a lesser extent by IL-6 
and TNFα. This is the irst study to identify sema3C, sema3D and their receptors within 
the nucleus pulposus of intervertebral discs. Immunopositivity shows signiicant 
increases in semaphorin3C, 3D and their receptor neuropilin-2 in degenerate samples 
which were shown to contain nerves and blood vessels, compared to non-degenerate 
samples without nerves and blood vessels. Therefore data presented here suggests 
that semaphorin3C may have a role in promoting innervation and vascularisation 
during degeneration, which may go on to cause low back pain.
INTRODUCTION
The intervertebral disc (IVD) is suggested to be the 
largest aneural and avascular tissue within the human body 
and is composed of three main anatomical regions; the 
gelatinous nucleus pulposus (NP) which is contained by the 
annulus ibrosus (AF) and the cartilaginous end plate (CEP). 
Chronic low back pain (LBP) is known to affect 80% of 
the population during their lifetime, and 40% of these cases 
are attributed to IVD degeneration [1]. Disc degeneration is 
characterised by the early loss of extracellular matrix (ECM) 
as well as altered biomechanical properties caused by an 
imbalance between anabolic and catabolic factors [2– 4]. 
Cytokines, in particular, interleukin-1 (IL-1) and tumour 
necrosis factor alpha (TNFα) are well known for their role 
within IVD degeneration [5–12], consequently leading to 
increased production of matrix degrading enzymes such as 
matrix metalloproteinases (MMPs); MMP-3 and -13, and 
a disintergrin and metalloproteinase with thrombospondin 
motifs (ADAMTS), -1, -4 and -5 [12–18]. The IVD is 
known to become increasingly vascularised by small blood 
vessels and innervated by peptide containing sensory nerve 
ibres, which are thought to elicit pain [19–21]. This being 
said, the mechanisms by which these processes occur are 
yet to be fully elucidated.
Current literature surrounding the mechanisms of 
low back pain (LBP) associated with neural ingrowth 
have focussed on neurotrophic factors which are 
known to promote the ingrowth and survival of sensory 
nerves, including nerve growth factor (NGF) and brain 
derived neurotrophic factor (BDNF) [19, 22–29]. To 
date however, limited studies have investigated the 
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potential role of axonal guidance molecules known as 
the Semaphorins. There are 8 classes of semaphorins, 
yet class 3 Semaphorins are the only secreted members 
of the semaphorin family found within vertebrates 
[30]. Initially semaphorins were thought to function as 
repulsive guidance cues, yet Sema3B and Sema3C have 
been postulated to have bi-functional properties involved 
in promotion and repulsion of axons [31–33]. Class 3 
semaphorins signal their response through two prominent 
semaphorin receptors; the neuropilins (NRP) and the 
plexins [34–38]. Whilst the majority of membrane bound 
semaphorins signal via plexins alone, class 3 semaphorins 
require the NRP as an obligate co-receptor, generating a 
high afinity holoreceptor complex [34, 37, 38].
Sema3A has previously been identiied within human 
IVD samples by immunohistochemistry (IHC) [39]. Tolofari 
et al., (2010) identiied immunopositive disc cells at the 
periphery of the outer annulus ibrosus (OAF) within non-
degenerate discs, however the number of immunopositive 
cells decreased in the OAF and increased within NP cells in 
degenerate discs [39]. Suggesting that Sema3A is a natural 
inhibitor present within the non-degenerate disc, preventing 
innervation and vascularisation. Yet during degeneration, 
the loss of Sema3A at the periphery could potentially allow 
the inappropriate entry of nerves and blood vessels into 
the AF [39]. However to date no studies have investigated 
expression of the remaining members of the semaphorins 
or their receptors and whether this expression is associated 
with the presence of nerves and blood vessels. Hence this 
study aimed to identify class 3 semaphorins (Sema3A-F) 
and their receptors within human NP tissue and identify 
whether their expression was regulated by pro-inlammatory 
cytokines. Importantly this study aimed to identify whether 
their expression was associated with the presence of nerves 
and blood vessels.
RESULTS
Identiication of class 3 semaphorins and their 
receptors within native NP tissue
Directly extracted NP cells were investigated by QRT-
PCR for the native expression of members of the class 3 
semaphorins and their receptors, of which Sema3A, 3C, 3D, 
3E and 3F along with NRP’s and Plexins were identiied 
within IVD tissue, irrespective of their classiication. 
Sema3B was not identiied in any sample. Sema3A 
was present in 100% of non-degenerate and degenerate 
samples, and 95% of iniltrated samples (Figure 1A). 
Sema3C and Sema3D were present in a greater number of 
degenerate samples compared to non-degenerate samples 
(P = < 0.05) (Figure 1B & 1C). Sema3C was present 78% 
of non-degenerate samples, rising signiicantly to 100% 
of iniltrated samples expressing sema3C (P = 0.0443) 
(Figure 1B). The proportion of samples expressing sema3D 
was signiicantly higher in the moderately degenerate 
(P = 0.0195), severely degenerate (P = 0.0004) and 
iniltrated (P = 0.0169) cohorts in comparison to 
non-degenerate cohort (Figure 1C). Sema3E was present 
in 100% of severely degenerate samples, a signiicantly 
higher proportion compared to expression in the moderately 
degenerate cohort (87%) (P = 0.05) (Figure 1D). Sema3F was 
expressed at low levels and present in 44% of non- degenerate 
samples, falling signiicantly to only 7% of moderately 
degenerate samples expressing sema3F (P = 0.0252) 
(Figure 1E). The proportion of severely degenerate samples 
expressing NRP1 was signiicantly higher than the number 
of non-degenerate samples expressing NRP1 (P = 0.0062) 
(Figure 1F). NRP2 was constitutively expressed by 100% 
of samples investigated, irrespective of disease classiication 
(Figure 1G). PA1 was expressed by a signiicantly higher 
proportion of samples in the severely degenerate (P = 
0.0448) and iniltrated cohorts (P = 0.0407) compared to non-
degenerate samples (Figure  1H). PA2 (Figure 1I) and PA4 
(Figure 1K) were expressed by a higher proportion of severely 
degenerate samples, compared to non-degenerate samples, yet 
this failed to reach signiicance. PA3 (Figure 1J) was expressed 
by 96% of severely degenerate samples, signiicantly higher 
than the number of non-degenerate samples expressing PA3 
(P = 0.0197) (Figure 1J).
Cytokine regulation of class 3 semaphorins within 
human NP cells, HDMEC and SH-SY5Y cells
Following the identiication of class 3 semaphorins 
and their receptors within native NP tissue, NP cells derived 
from degenerate IVDs were cultured in alginate and 
stimulated with pro-inlammatory cytokines, to determine 
modulation by inlammatory cytokines. Following IL-1β 
treatment for 48 hours, human NP cells signiicantly up 
regulated their expression of Sema3C at concentrations 
≥ 1 pg/mL (P ≤ 0.05) (Figure 2A) and Sema3D at 
concentrations ≥ 100 pg/mL (P ≤ 0.0001) (Figure 2A). IL-6 
and TNFα treatment in human NP cells failed to regulate 
semaphorins (P = > 0.05) (Figure 2B & 2C).
HDMEC stimulation with 10 ng/mL IL-1β signii-
cantly increased Sema3C (P = 0.0007) whilst sema3A was 
signiicantly decreased (P = 0.0071) (Figure 2D). IL-6, 
IL-8 and TNFα failed to regulate semaphorin expression 
in HDMEC or SHSY5Y cells, IL-1β also had no effect on 
SHSY5Y cells (Figure 2D & 2E).
Cytokine regulation of neuropilins and plexins 
within human NP cells, HDMEC and SH-SY5Y 
cells
IL-1β induced a signiicant up regulation of NRP2 in 
NP cells (P = ≤ 0.0001) (Figure 3A) however NRP1 was 
not signiicantly regulated and no regulation was observed 
within HDMEC or SHSY5Y cells (Figure 3D, 3E). Whilst 
IL-6, IL-8 and TNFα failed to signiicantly regulate NRP1 
or NRP2 in all cell types investigated (Figure 3B–3E).
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All plexins were identiied within native IVD tissue 
(Figure 1F–1I). Within human NP cells, PA1 PA2 and PA3 
were signiicantly increased by IL-1β treatment (P < 0.05) 
(Figure 4A) whilst PA4 was not regulated (Figure 4A). 
IL-6 treatment signiicantly increased PA1 (P = 0.03) 
but failed to regulate other plexins (Figure 4B). TNFα 
Figure 1: Identiication of class 3 semaphorins and their receptors within native IVD tissue. Percentage expression is 
represented as the number of disc samples in each cohort that expressed the target gene, with the mean value shown by the bar. Sema3A 
A. was present in 100% of non-degenerate and degenerate samples with 95% of iniltrated samples expressing Sema3A. Sema3C B. was 
present in 78% of samples graded < 4, however expression was present in 100% of severely degenerate (grade > 7) and iniltrated samples. 
Sema3D C. was expressed in 80% of moderately degenerate samples (grade 4–7) and 93% of severely degenerate samples (grade > 7). 
Sema3E D. was present in 89% of non-degenerate samples, increasing to 100% of samples in the severely degenerate cohort expressing 
Sema3E. Sema3F E. expression was present in 44% of non-degenerate samples, yet sema3F was only present in 1 sample (7%) of 
moderately degenerate samples. NRP1 F. expression levels increased from 44% expression in non-degenerate samples to 89% of severely 
degenerate samples expressing the receptor. NRP2 G. was present in 100% of samples regardless of disease classiication. PlexinA1 H. 
was present in more degenerate samples than those graded as non-degenerate. PlexinA2 I. was present in 56% of non-degenerate samples, 
rising to 82% expression in severely degenerate samples. PlexinA3 J. was present in 96% of severely degenerate samples, and PlexinA4 
K. was expressed by 22% of non-degenerate samples; increasing to 68% expression in the severely degenerate cohort. No signiicance was 
identiied between expression levels and grades of degeneration. Statistical analysis was performed on proportions expressed P = < 0.05.
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Figure 2: Cytokine regulation of Class 3 Semaphorins in human NP cells treated with IL-1β A. IL-6 B. and TNFα C. 
HDMECs D. and SH-SY5Y E. cells were treated with 10 ng/mL of IL-1β, IL-6, IL-8 or TNFα. Sema3C and Sema3D were 
signiicantly up regulated by IL-1β treatment (P = ≤ 0.05) (A). IL-6 failed to regulate cytokine expression within human NP cells (B). TNFα caused 
a non-signiicant increase in Sema3C and Sema3D (C) IL-1β signiicantly up regulated Sema3C from HDMEC cells, and caused a signiicant down 
regulation in Sema3A (D). SH-SY5Y cell stimulation with all cytokines caused non-signiicant increases in Sema3A, Sema3C and Sema3D (E).
Oncotarget18342www.impactjournals.com/oncotarget
Figure 3: Cytokine regulation of Neuropilin-1 and Neuropilin-2 in human NP cells treated with IL-1 A. IL-6 B. TNFα C. 
and HDMECs D. and SH-SY5Y E. Cells were treated with 10 ng/mL of IL-1, IL-6, IL-8 and TNFα. In human NP cells, IL-1β caused down 
regulation of NRP1, and a signiicant up regulation of NRP2 (P = ≤ 0.05) (A) Small but non-signiicant increases in NRP2 were seen in HDMECs 
in response to IL6 and IL-8 (D). TNFα stimulation appeared to cause a small increase in NRP1 and NRP2 expression, yet this was not signiicant (E)
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Figure 4: Cytokine regulation of Plexins (A1-A4) in human NP cells treated with IL-1 A. IL-6 B. TNFα C. and HDMECs 
D. and SH-SY5Y E. Cells were treated with 10 ng/mL of IL-1, IL-6, IL-8 and TNFα. IL-1β (A) and IL-6 (B) signiicantly up regulated PA1 
in human NP cells, whilst IL-1β also signiicantly up regulated PA2 and PA3 (A) in human NP cells. A non-signiicant decrease in PA4 was 
seen in response to IL-1β treatment at 1 ng/mL (A) PA2 was signiicantly down regulated in response to 10 ng/mL TNFα treatment in human 
NP cells (P = ≤ 0.05) (C) Plexin expression was not regulated by cytokines in HDMEC cells (D) Small but non-signiicant increases in PA3 
expression were seen in SHSY5Y cells in response to all cytokines; however PA4 was non-signiicantly decreased by IL-6, IL-8 and TNFα (E)
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induced a signiicant decrease in PA2 following 100 ng/ml 
stimulation (P = 0.0065), but failed to regulate other 
plexins (Figure 4C). Plexin expression was not regulated 
by cytokines within HDMEC cells (Figure 4D) or SH-
SY5Y cells (Figure 4E).
Immunodetection of semaphorins and their 
receptors within human IVD tissue
Immunopositivity was irst identiied for NF200 and 
CD31 to determine patient samples with the presence of 
nerves (NF200+) and blood vessels (CD31+) within NP 
tissue (Figure 5A–5B). Semaphorin 3C, sema3D and their 
receptors NRP1, NRP2 and PA1 were investigated for 
their presence in NP tissue and their association with nerve 
and blood vessels (Figure 5C–5G). (Four groups were 
investigated: ND-/-: non-degenerate NF200-/CD31-. D-/- : 
Degenerate NF200-/CD31-. D+/+: Degenerate NF200+/
CD31+. D+/-: Degenerate NF200+/CD31-), note speciic 
grade of degeneration within each group was not seperated 
for investigation as this would have resulted in 7 groups 
and reduced the number of samples within each group.
Co-localisation of CD31 and target molecules was 
performed on serial sections and demonstrates a strong co-
localisation of CD31 and NRP1, NRP2 and PA1 (Figure 6). 
Sema3C and sema3D expression is not directly co-localised 
with the blood vessels, yet surrounding cells do express 
sema3C and sema3D (Figure 6). Nerve identiication on 
tissues not stained with NF200 was dificult to localise, and 
thus co-localisation was not possible.
Expression levels of sema3C were signiicantly 
higher in the D+/+ group compared to the ND-/- group 
(P = 0.0118) (Figure 7A). PM samples demonstrate 
lower levels of expression of sema3C compared to 
surgically painful samples, particularly in the D-/- cohort 
(Figure 7A). A signiicant positive correlation between 
immunopositivity and grade of degeneration was seen 
in the PM cohort alone (P = 0.0124) (Supplementary 
Figure 1), yet when the data is combined with the surgical 
cohort, signiicance was lost due to variation seen in the 
surgical cohort (P = 0.2901).
Sema3D was expressed in 100% of ND-/- samples 
and D+/+ samples, decreasing to 93% of patients in the 
D-/- cohort (Figure 7B). Sema3D expression levels was 
signiicantly higher in the D-/- compared to D+/- group 
(P = 0.0147). Again, as with sema3C, sema3D expression 
levels in the PM samples in the D-/- and D+/+ were very 
low compared to the surgical painful samples, yet no 
signiicance was seen due to patient variation (Figure 7B). 
A signiicant correlation between sema3D expression and 
grade of degeneration was seen within the PM cohort 
alone (P = 0.0099) (Figure 7F).
NRP1 immunopositivity was detected in 
100% of ND-/-, D-/- and D+/+ patients samples, yet 
in the degenerate cohort with nerves and lacking 
blood vessels, NRP1 expression levels decreased 
to 89% (Figure 7C). Expression levels between 
the cohorts did not show signiicant differences 
due to variation between the surgical and PM, as 
shown in red, the PM samples showed much lower 
levels of expression in each cohort (Figure 7C). 
Immunopositivity of NRP1 and grade of degeneration 
were signiicantly correlated in the surgical cohort 
(P = 0.039), yet no signiicance were seen within the PM 
cohort or when the samples were combined (Figure 7F).
NRP2 immunopositivity in the surgical cohort 
alone, showed signiicantly higher expression levels 
in the D-/- (P = 0.0008), D+/+ (P = 0.0213) and D+/- 
(P = 0.0213) cohorts compared to the ND-/- cohort. 
When surgical and PM samples were combined, 
expression levels in the D-/- group were signiicantly 
higher than in the ND-/- (P = 0.0069) group. 
Immunopositivity in the D-/- group was signiicantly 
lower than in the D+/- group (P = 0.0437) (Figure 7D). 
A strong positive correlation was shown between NRP2 
immunopositivity and grade of degeneration in the 
surgical cohort alone (P = 0.0203), yet when the data 
was combined with the PM samples, correlation was 
lost (Figure 7F).
PA1 was expressed in 100% of samples in the 
ND-/-, D-/- and D+/+ and 95% D+/- samples (Figure 7E). 
Immunopositivity levels were signiicantly higher in 
the D+/- group compared to the ND-/- (P = 0.0161). 
PM samples demonstrated much lower levels of PA1 
expression as opposed to the painful surgical samples 
(Figure 7E). PA1 expression levels show a signiicant 
positive correlation between immunopositivity and grade 
of degeneration in the surgical cohort (P = 0.0055), yet due 
to the lack of correlation in the PM cohort, signiicance 
was lost when the data was combined (Figure 7F).
Correlations between semaphorin and their 
receptor expression in human NP cells
Positive correlations were evident when data from 
PM and surgical were combined for the expression 
of sema3C and their receptors; NRP1 (P = < 0.0001) 
(Supplementary Figure 1A), NRP2 (P = 0.0008) 
(Supplementary Figure 1B), and PA1 (P = < 0.0001) 
(Supplementary Figure 1C). Likewise, correlations 
between sema3D and its receptors were seen NRP1 
(P = 0.0002) (Supplementary Figure 1D) NRP2 
(P = 0.0003) (Supplementary Figure 1E) and PA1 
(P = 0.0001) (Supplementary Figure 1F).
Positive correlation was identiied between 
immunopositivity of sema3C and sema3D (P = < 
0.0001) (Supplementary Figure 2A), NRP1 and NRP2 (P 
= < 0.0001) (Supplementary Figure 2B), NRP1 and PA1 
(P = < 0.0001) (Supplementary Figure 2C), and NRP2 and 
PA1 (P = < 0.0001) (Supplementary Figure 2D).
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Figure 5: Immunopositivity of class 3 semaphorins and their receptors within the IVD. Four groups were investigated for 
the expression of sema3C, sema3D and their receptors, NRP1, NRP2 and PA1 in tissues which were of differing grade of degeneration 
and whether nerve and/or blood vessels were present. (ND-/-: non-degenerate NF200-/CD31-. D-/-: Degenerate NF200-/CD31-. D+/+: 
Degenerate NF200+/CD31+. D+/-: Degenerate NF200+/CD31-).
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Figure 6: Co-localisation of CD31 and sema3C, sema3D and receptors NRP1, NRP2 and PA1 immunopositivity within 
human IVD tissue. This demonstrates a link between localisation of CD31 and Sema3C, Sema3D, PA1 and the NRP’s which are known 
to be co-receptors for VEGFR.
Oncotarget18347www.impactjournals.com/oncotarget
Figure 7: Immunopositivity of sema3C A. sema3D B. NRP1 C. NRP2 D. and PA1 E. in human NP tissues from 
surgically painful IVD’s (green) and non-painful PM IVD’s (red). Samples were split into different cohorts irstly based on 
histological degeneration and then on the identiication of NF200+ and CD31+ tissue which indicates the presence of nerve and blood 
vessels. Immunopositivity for all molecules was generally higher in the surgically painful IVDs than in the PM samples, with signiicance 
reported in immunopositivity levels between the ND-/- and D+/+ for sema3C (A) and NRP2 (D) Correlation of immunopositivity and grade 
of degeneration was analysed and P values were recorded F. Sema3C and Sema3D immunopositivity showed a strong correlation with 
grade of degeneration in the PM samples alone, when the data was combined for surgical and PM discs, correlation was lost due to variation 
(F) NRP1, NRP2 and PA1 demonstrated strong correlation between immunopositivity and grade of degeneration in the painfully surgical 
samples, yet correlation was lost when data was combined with PM samples (F).
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DISCUSSION
It is postulated that the ingrowth of nociceptive 
nerves and blood vessels into the degenerate IVD may 
be involved in the generation of chronic back pain [19, 
28], yet the mechanisms involved in innervation and 
vascularisation of the IVD remain largely unknown. 
Recent studies have focused heavily on the presence 
of neurotrophic and angiogenic factors, in the hope of 
identifying a key player involved in the ingrowth into 
diseased discs [24, 25, 29, 43–46]. However only one 
paper to date has investigated the role of semaphorins 
which are thought to be inhibitory by nature to nerve and 
blood vessel ingrowth within the degenerate IVD [39]. 
Here, all class 3 semaphorins and their receptors at mRNA 
level were investigated, together with their regulation by 
cytokines known to be up regulated within the degenerate 
IVD. Further to this, sema3C, sema3D and their receptors 
were investigated for their protein expression within IVD 
tissues in association with nerve and blood vessels.
Members of the class 3 semaphorins are primarily 
known for their role in axonal pathinding during 
development [47, 48], as well as having implications in 
angiogenesis and the immune system [49–51] amongst 
others [50].
Here, sema3A, sema3C, sema3D, sema3E, sema3F 
and their receptors the NRPs and PA1-A4 were identiied 
at mRNA level in native NP cells. Although no signiicant 
changes in expression levels between the degenerate 
cohorts were identiied, it is interesting that the majority 
of samples, particularly in the diseased state expressed 
these molecules. In contrast to the previous study, sema3A 
expression was evident in 100% of IVD tissues regardless 
of grade of degeneration, whereas Tolofari et al., (2010) 
showed sema3A expression in 57% of healthy NP and 
33% degenerate NP samples [39]. In addition to this, 
NRP1 was expressed by 89% of our severely degenerate 
DE NP samples; yet Tolofari et al., (2010) did not see any 
expression of NRP1 in the healthy NP cohort but 60% 
of degenerate NP samples expressed NRP1. NRP2 was 
constitutively expressed by NP cells regardless of disease 
state in our study, however low levels were seen in both 
healthy and degenerate NP in the previous study. Plexin 
expression was evident in all disease states, yet Tolofari et 
al., (2010) did not identify PA1 in any sample, and only 
found PA2 in degenerate NP samples. The discrepancies 
in expression between the two studies could be due to 
the sensitivity of quantitative real-time PCR used here 
on more patient samples as opposed to standard real time 
PCR used in the previous study on 7 NP samples.
As the semaphorins are heavily involved in the 
repulsion of nerves and blood vessels in other systems and 
particularly during development, it was postulated that the 
expression of semaphorins would decrease in degenerate 
IVD’s where innervation and angiogenesis is evident. 
Tolofari et al., (2010) described increases in PGP9.5 (a nerve 
ibre marker) and CD31 mRNA expression which correlated 
with low sema3A mRNA expression in degenerate AF tissue, 
thus suggesting that sema3A is a natural inhibitor of nerve 
and blood vessel ingrowth in healthy AF [39], however 
increased expression was seen in the NP. Not only did we 
identify the presence of semaphorins at mRNA level, but 
furthered this with the native localisation and expression of 
sema3C and sema3D in association with nerve and blood 
vessels at protein level in the NP.
Immunohistochemistry analysis revealed strong 
positive correlations between sema3C and sema3D 
expression with grade of degeneration within the non-
painful PM samples alone, interestingly however, 
correlation was lost when combined with the painful 
surgical samples due to varied expression. On the contrary, 
NRP1, NRP2 and PA1 demonstrated strong positive 
correlations with grade of degeneration in the surgically 
painful IVD’s alone. This data goes against the original 
hypothesis that semaphorins would decrease as the 
severity of degeneration occurs. However this being said, 
highly degenerate IVD’s may not necessarily be painful 
and/or contain nerves and blood vessels [4], which we 
have shown to be the case; hence here we investigated 
the expression in association with grade and the presence/
absence of nerve and blood vessel ingrowth. Although 
all surgical samples used in this study were taken from 
patients experiencing pain, it proves dificult to determine 
the source of pain; it could be postulated that those tissues 
that were histologically graded as ND-/- or D-/- may be 
experiencing pain solely from compression or irritation 
of the nerve root due to herniation of the IVD. Whereas, 
samples that do have nerves and/or blood vessels 
present, may have a heightened response to pain due to 
the presence of nociceptive nerve ibres. Both sema3C 
and sema3D were identiied in all NP samples in the 
ND-/- cohort, however the percentage immunopositivity 
for sema3C and sema3D increased in degenerate tissue 
samples with evidence of nerve and blood vessels. 
Surgically painful degenerate IVD’s demonstrated a 
higher expression of both sema3C and sema3D compared 
to non-painful PM tissues; suggesting a possible attractive 
role rather than repulsion. Similarly, levels of NRP1 
and PA1 from surgically painful degenerate IVD’s 
were higher than those of non-painful PM tissue. NRP2 
immunopositivity levels were more varied between non-
painful PM samples. The higher immunopositivity levels 
in painful surgical samples indicate a more prominent 
role for semaphorins in painful surgical samples. It must 
be taken into account that the preparation of the surgical 
and PM samples were different, and the PM samples 
processed at Utrecht may have been subject to antigen 
destruction during decalciication which could explain 
the overall decreased levels of immunopositivity in 
these samples. Sema3C and sema3D immunopositivity 
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demonstrated strong correlations with their receptors. 
This data indicates that sema3C and sema3D may have an 
active role in degeneration as there is a corresponding up 
regulation in their receptors. Sema3C has been described 
as a bi- functional semaphorin as it can also attract cells 
such as mouse glomerular endothelial cells, in a similar 
fashion to that seen by VEGF [52]. In this study, all 
samples where nerves and blood vessels were absent were 
positive for sema3C. Initially, this suggests that sema3C 
may have a protective role against nerve and blood vessel 
ingrowth. However, in the degenerate cohorts with evident 
nerve and blood vessel ingrowth, immunopositivity levels 
were signiicantly higher compared to negative/negative 
samples, indicating that sema3C may have a bi-functional 
role within the IVD to promote ingrowth of blood vessels 
and nerve ibres.
Although sema3D has not been characterised 
as well as other members of the class 3 semaphorins, 
it too has been shown to possess chemorepellent and 
chemoattractant properties towards neurons within the 
CNS of zebraish depending on the composition of the 
NRP molecule [53]. Immunopositivity of sema3D was 
seen in very high proportions of IVD samples regardless 
of whether nerves and blood vessels were present. 
However levels of sema3D expression in the degenerate 
cohort with nerves but no blood vessels, was lower than 
in the degenerate negative/negative cohort indicating that 
sema3D may be involved in the chemoattraction of nerves 
but not blood vessels.
Sema3C and sema3D both bind to NRP1 and NRP2 
with equal afinity, immunopositivity levels of NRP1 and 
NRP2 were higher in the degenerate negative/negative 
samples compared to the non-degenerate negative/
negative samples suggesting a possible role for the NRPs 
in degeneration. NRP’s are a co-receptor for VEGF as well 
as semaphorins, and VEGF is known to be up regulated 
by cytokines within human NP cells within the degenerate 
disc [29]. This study demonstrated a strong co-localisation 
with endothelial cells and NRP1, NRP2 and PA1 which 
are known co-receptors for VEGFR binding.
Regulatory studies performed here demonstrate for 
the irst time that class 3 semaphorins and their receptors 
are susceptible to regulation by inlammatory cytokines 
particularly IL-1β, in human NP cells. Cytokines are 
well known for their role in human IVD degeneration, 
and they have recently been shown to regulate the 
expression of neurotrophic factors, particularly NGF and 
BDNF in human NP cells [22, 26, 29]. This suggests 
a function for these molecules in the promotion and 
survival of nerve and blood vessel ingrowth into the 
degenerate IVD. However, as indicated above there may 
be a role for the semaphorins in the advocacy of nerve 
and blood vessel ingrowth as their expression from 
human NP cells in degenerate tissue with/without nerves 
and blood vessels differs to non-degenerate negative/
negative samples.
Interestingly, sema3C and sema3D were more 
responsive to cytokine stimulation than other more 
characterised semaphorins, showing signiicant up 
regulations in response to as little as 10 pg/mL IL-1β 
stimulation. Semaphorins were not regulated by IL-6 
or TNFα in human NP cells, thus suggesting a key 
role for IL-1β in this process. Likewise, regulation of 
semaphorin receptors was more prominent in response 
to IL-1β stimulation than IL-6 or TNFα. Stimulation 
with IL-1β induced NRP2 and plexin expression. A 
previous study relating to human proximal tubular cells 
demonstrated similar trends after IL-1β stimulation in 
that NRP1 decreased, and NRP2 increased [54]. From 
the data presented here, it could be hypothesised that 
cytokines within the degenerate NP, stimulate the up 
regulation of sema3C and sema3D and, as previously 
shown NGF and VEGF [29] which are factors known 
to promote the survival and proliferation of nerve and 
blood vessels. Additionally IL-1β increased sema3C 
expression in endothelial cells which could intensify the 
chemoattraction of nerves along with the expression of 
NGF which we already know endothelial cells present 
in the human NP express [19]. We have shown that a 
nerve cell line (SHSY5Y) expresses NRP1, NRP2 and 
PA1-A4, however; although there is an up regulation of 
semaphorins from NP cells upon cytokine stimulation, 
the receptors are not regulated by cytokines in a nerve 
cell line or endothelial cells suggesting that nerve 
and blood vessels within the diseased IVD may not 
respond to cytokines from NP cells. The responses of 
NP, nerve and blood vessels to semaphorins need to 
be further investigated to identify if the receptors are 
active and able to exert the effects of semaphorins in the 
environment of the disc.
The interplay between biological and mechanical 
inluences within the degenerative process has recently 
become a focus point within research, with many groups 
investigating the link between mechanical affects and 
biological outcomes. It is widely thought that multiple 
factors are involved in the generation of LBP, recent 
studies have highlighted a potential relationship between 
modic changes [55, 56] and low grade bacterial infection 
[57] in the production of pain, as both compromise the 
structural integrity of the vertebral body.
A possible initiating factor of IVD degeneration is the 
disruption of the vertebral end plate; this is known to result in 
increased catabolic enzyme production which degrade matrix 
molecules such as aggrecan. The loss of such proteoglycans 
is primarily known for its effect on disc hydration, yet the 
loss of disc height and pressure alterations within the NP can 
lead to extensive issuring seen in degenerate IVD’s [58]. 
Stefanakis et al., (2012) reported strong localisation of nerve 
and blood vessels to annular issures due to its conducive 
environment to nerves and blood vessels [58]; hence 
providing a likely route into the deeper layers of the IVD. 
Data presented here show that nerves and blood vessels were 
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present both next to and distant from issures, yet it has to be 
taken into account that this study is based on 10 μm sections 
from herniated tissues, and PM samples. Ideally whole 
human IVDs would have been serially sectioned and stained 
to form a 3D model highlighting the pathway and localisation 
of nerve and blood vessels within the IVD. Recent studies by 
Gawri et al., (2014) demonstrated an increased production 
of inlammatory factors such as NGF, TNFα and IL-6 from 
IVD cells under high mechanical strain [43]; thus suggesting 
that abnormal strain on the human IVD could potentiate 
or drive the inlammatory process that occurs during 
degeneration which may advocate the ingrowth of nerves 
and blood vessels. Results presented here, demonstrate an 
increased production of semaphorins and their receptors (also 
known to be involved in angiogenesis) in response to such 
inlammatory factors. This taken alongside recent studies 
focussing on mechanical cues could implicate a multifactorial 
process which ultimately accelerates disc degeneration.
MATERIALS AND METHODS
Human tissue
Human IVD tissue was obtained from surgery or 
post mortem examination (processed within 72 hours after 
death) with informed consent of the patient or relatives. 
Ethical approval was obtained from Shefield Research 
Ethics Committee (09/H1308/70) for 89 surgical IVD 
samples from 89 individuals, and 4 post mortem (PM) 
samples from 2 individuals, and 18 PM samples from the 
department of Pathology/UMCU Biobank, UMC Utrecht, 
used in line with the code of proper secondary use of 
human tissue (Supplementary Table 1).
Tissue processing
Tissue processed at Shefield Hallam University 
consisting of AF and NP was ixed in 10% neutral buffered 
formalin, and processed to parafin wax. Tissue processed at 
Utrecht was obtained 24 hours after death and IVD slices were 
decalciied in Kristensen’s solution (50% formic acid, and 
68 g/l sodium formate) in a microwave at 150 W and 50°C for 
6 hours as previously published [40]. Sections were dehydrated 
and rinsed in xylene before being embedded to parafin wax. 
Following embedding, 4 μm sections cut and histologically 
graded using previously published criteria [12, 29].
Investigation of class 3 semaphorins and their 
receptors within native NP cells
Samples from degenerate IVD tissue were obtained 
from 69 patients undergoing microdiscectomy for the 
treatment of low back pain which mainly consisted of NP 
tissue, and 2 PM samples from 1 patient were used. NP 
tissue was separated from contaminating AF and CEP and 
digested with 2 U/ml protease (Sigma, UK) in DMEM 
for 30 minutes at 37°C, and washed twice with DMEM. 
Following this, NP cells were isolated using 2 mg/mL 
collagenase type 1 (Sigma, UK) for 4 hours at 37°C. Cells 
were passed through a 40 μM cell strainer (Invitrogen, UK) 
as previously published [41]. Following extraction cells 
were either used for direct RNA extraction or cell culture. 
RNA and cDNA was synthesised as previously published 
[42] [42]. Target genes were investigated using QRT-PCR.
Quantitative real-time polymerase chain reaction 
(QRT-PCR) was conducted on 9 non-degenerate samples 
(grade < 4) from 9 patients, 15 moderately degenerate 
samples (grade grade 4 -7) from 15 patients, and 28 
severely degenerate samples (grade > 7) from 28 patients, 
and 20 samples with evident iniltration from patients 
experiencing pain (Supplementary Table 1).
QRT-PCR was performed on a StepOnePlus™ Real-
Time PCR System (Applied Biosystems, UK) in order to 
investigate gene expression levels of Semaphorin3A-F and 
their receptors, NRP1 and NRP2, along with PlexinA1-A4 
(PA1-PA4)(Pre-designed primer/probe mixes Applied 
Biosystems, UK) within directly extracted samples from 
degenerate and non-degenerate samples. Glyceraldehyde-
3-phosphate dehydrogenase (GAPDH) and 18S (Applied 
Biosystems, UK) were used as housekeeping genes to allow 
normalisation. Ten microliter reactions were prepared using 
TaqMan Universal PCR Master Mix (Applied Biosystems, 
UK). Results were analysed using the 2−ΔCt method and 
presented as relative gene expression normalised to the 
average C
T
 for the two housekeeping genes.
Cytokine regulation of class 3 semaphorins and 
their receptors in human NP cells, SH-SY5Y cells 
and HDMEC cells
NP cell culture
Following extraction NP cells were cultured for 
expansion in monolayer in DMEM supplemented with 
10% v/v heat inactivated foetal calf serum (FCS), 100 
U/ml Penicillin, 100 μg/ml Streptomycin, 250 ng/ml 
amphotericin, 2 mM glutamine (Invitrogen, UK) and 50 μg/
ml ascorbic acid (Sigma Aldrich, UK) (Complete cell culture 
media) and maintained at 37°C in a humidiied atmosphere 
containing 5% CO
2
. Complete culture media was changed 
every 3 days. Following expansion in monolayer up to 
passage 2, NP cells were resuspended in 1.2% medium 
viscosity sodium alginate (Sigma Aldrich, UK) at 4 × 106 
cells/ml and alginate beads as previously published [12]. All 
NP cells used in this experiment were cultured in alginate 
for 2 weeks prior to cytokine treatments to enable cells to 
regain native cellular phenotypes [12].
Monolayer SH-SY5Y and HDMEC cell culture
SH-SY5Y neuroblastoma cells were differentiated 
by a 7 day pre-treatment with 5 μM of retinoic acid prior 
to seeding into a 6 well plate at a cell density of 5 × 105 
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cells/well. Human dermal microvascular endothelial cells 
(HDMECs) were seeded into 6 well plates at a density 
of 1 × 106 cells/well in complete HDMEC growth factor 
media (PromoCell, UK).
Cytokine treatments
Following 2 weeks culture in alginate beads, NP 
cells were treated with pro-inlammatory cytokines: IL-
1β, IL-6 and TNFα (Peprotech, UK) for 48 hours. NP cells 
were treated with IL-6 and TNFα at 0, 1, 10 and100 ng/mL 
in serum free media in triplicate on 3 independent patients. 
IL-1β treatments were performed on 5 patients in triplicate 
(0, 1, 10, 100 ng/mL) and on 3 patients in triplicate at 
a wider concentration range (0, 0.001, 0.01, 0.1, 1, 10 
and 100 ng/mL) for 48 hours to identify dose responses. 
SH-SY5Y and HDMEC cells were allowed to adhere for 
24 hours prior to stimulation with 10 ng/mL IL-1β, IL-6, 
IL-8 or TNFα for 48 hours.
Following cytokine treatments, alginate beads were 
washed in 0.15 M NaCl and dissolved by application 
of alginate dissolving buffer (55 mM sodium citrate 
(Na3C6H5O7), 30 mM Na EDTA and 0.15 M NaCl at pH6.8) for 15 minutes at 37°C followed by digestion of extracellular 
matrix in 0.06% w/v collagenase type 1 (Sigma, UK) for 
30 minutes. RNA was extracted and cDNA synthesised 
and QRT-PCR used to investigate expression levels of 
semaphorins and their receptors as described above.
Immunohistochemistry
Initial investigations to identify NF200 
(neuroilament 200, nerve marker) and CD31 (blood 
vessel marker) immunopositivity was performed in order 
to further investigate the relationship between the presence 
of nerve and blood vessels and the expression of factors 
involved in their survival in human NP tissue.
Tissues samples were selected which contained 
NP and AF tissue and were grouped into the following 
categories based on the identiication of nerves (NF200+) 
and blood vessels (CD31+) in tissues which had been 
histologically graded. Non-degenerate tissues (grade < 4) 
NF200-/CD31- (ND-/-)(n = 5), Degenerate tissues 
(grade > 4) NF200-/CD31- (D-/-)(n = 14), Degenerate 
(grade > 4) NF200+/CD31+ (D+/+)(n = 14) and 
Degenerate (grade > 4) NF200+/CD31- (D+/-) (n = 19). 
No disc samples were identiied which displayed NF200-/
CD31+ proile and hence this group was not investigated. 
Post mortem tissue was utilised to enable localisation of 
nerves and blood vessels within the different regions.
Studies were conducted on the above cohorts to 
investigate the expression of class 3 semaphorins, Sema3C 
and Sema3D and their receptors NRP1, NRP2 and PA1 
and their association with tissues with nerves and blood 
vessels using immunohistochemistry as per Le Maitre 
et al., (2004) [13].
Briely, four micron sections were dewaxed, 
rehydrated, and endogenous peroxidase blocked. Antigen 
retrieval methods were performed (Supplementary Table 2). 
Following TBS washes, nonspeciic binding sites were 
blocked at room temperature for 2 hours with either 25% w/v 
goat or rabbit serum (Abcam, UK) in 1% w/v bovine serum 
albumin (Sigma, UK) in TBS (Supplementary Table 2). 
Sections were incubated overnight at 4°C with either mouse 
or rabbit polyclonal antibodies (Supplementary Table 2). 
Negative controls in which rabbit and mouse IgGs (Abcam, 
UK) replaced the primary antibody at an equal protein 
concentration were used. Slides were washed in TBS and a 
1:500 dilution of 1% w/v BSA/TBS biotinylated secondary 
antibody was applied for 30 minutes at room temperature 
(Supplementary Table 2). Binding of the secondary 
antibody was disclosed with streptavidin-biotin complex 
(Vector Laboratories, UK) technique with 0.08% v/v 
hydrogen peroxide in 0.65 mg/mL 3, 3′-diaminobenzidine 
tetrahydrochloride (Sigma, UK) in TBS. Sections were 
counterstained with Mayer’s haematoxylin (Leica, UK), 
dehydrated, cleared and mounted with Pertex (Leica, UK).
All slides were visualised using an Olympus 
BX60 microscope and images captured using a digital 
camera and software program QCapture Pro v8.0 
(MediaCybernetics, UK). Evaluation of IHC staining 
was performed by counting a minimum of 200 NP cells 
as immunopositive or immunonegative; immunopositive 
cells were expressed as a percentage of total count.
Statistical analysis
Data was shown to be non-parametric and hence a 
Kruskall-Wallis with Conover-Inman post hoc analysis 
test was used to identify signiicant differences between 
cytokine treatments on human NP cells as well as differences 
between patient cohorts investigated by IHC (P ≤ 0.05). Two 
independent proportionality tests were performed to identify 
differences between the proportions of samples expressing 
the target molecules in the DE sample cohorts (P ≤ 0.05). 
Linear regression analysis was performed to assess the 
correlation between target molecules used in IHC (P ≤ 0.05).
CONCLUSION
Previous research into painful intervertebral discs 
found associations with nerve and blood vessels and 
painful discs, with suggestions that blood vessels enter the 
IVD irst, expressing NGF which promotes the in growth 
of nerves [19, 28]. Yet research presented here, suggests 
that nerves are able to innervate the NP without endothelial 
cell protrusion irst; further research on a larger cohort 
of samples should be performed to conirm this inding. 
The current study suggests that members of the class 3 
semaphorins may be implicated in the ingrowth of nerves 
and blood vessels in the degenerate NP of surgically painful 
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IVDs, in particular sema3C and sema3D which according 
to previous research in other systems are thought to have 
potential chemoattractive functions. Further research is 
required to conirm the function of these molecules on 
nerves and blood vessels in conjunction with human NP 
cells, in a degenerate environment. To conclude, this study 
implicates a role for sema3C and sema3D in the innervation 
and vascularisation of the human IVD during degeneration, 
which is postulated to be a cause of chronic low back pain.
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